(Q41277218)

29 September 2017

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models (English)

1 reference

29 September 2017

M Heilig

1

0 references

author name string

B Söderpalm

series ordinal

2

1 reference

29 September 2017

J A Engel

series ordinal

3

1 reference

29 September 2017

E Widerlöv

series ordinal

4

1 reference

29 September 2017

1 January 1989

1 reference

29 September 2017

1 reference

29 September 2017

98

1 reference

29 September 2017

524-529

1 reference

29 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00441953

29 September 2017

0 references

cites work

Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides

1 reference

12 December 2020

Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function

1 reference

12 December 2020

Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat

1 reference

12 December 2020

Neuropeptide Y (NPY) and the central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders

1 reference

12 December 2020

Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat.

1 reference

12 December 2020

Neuropeptide Y receptor in the rat brain.

1 reference

12 December 2020

Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

1 reference

12 December 2020

Neuropeptide Y: a potent inducer of consummatory behavior in rats

1 reference

12 December 2020

Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat

1 reference

12 December 2020

II. New evidence for a locus coeruleus-norepinephrine connection with anxiety

1 reference

12 December 2020

Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat.

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

1 reference

12 December 2020

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

1 reference

12 December 2020

Plasma corticosterone and brain catecholamines in stress: Effect of psychotropic drugs

1 reference

12 December 2020

Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat.

1 reference

12 December 2020

Actions of centrally administered neuropeptide Y on EEG activity in different rat strains and in different phases of their circadian cycle.

1 reference

12 December 2020

Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors

1 reference

12 December 2020

The relation between fear induced by novel stimulation and exploratory behavior.

1 reference

12 December 2020

Neuropeptide Y in vitro selectively increases the number of α2-adrenergic binding sites in membranes of the medulla oblongata of the rat

1 reference

12 December 2020

Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors.

1 reference

12 December 2020

Neurotransmitters, anxiety and benzodiazepines: a behavioral review

1 reference

12 December 2020

Autonomic and psychic effects of yohimbine hydrochloride

1 reference

12 December 2020

Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain

1 reference

12 December 2020

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

1 reference

12 December 2020

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

12 December 2020

Norepinephrine-like effects of neuropeptide Y on LH release in the rat

1 reference

12 December 2020

Avian pancreatic polypeptide phase shifts hamster circadian rhythms when microinjected into the suprachiasmatic region

1 reference

12 December 2020

Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat

1 reference

12 December 2020

Neuropharmacological studies in rodents on the action of RX 781094, a new selective α2-adrenoceptor antagonist

1 reference

12 December 2020

Modulation of memory processing by neuropeptide Y.

1 reference

12 December 2020

Anticonflict and rotarod impairing effects of alprazolam and diazepam in rat after acute and subchronic administration.

1 reference

12 December 2020

Neuropeptide Y distribution in human brain

1 reference

12 December 2020

A simple and reliable conflict procedure for testing anti-anxiety agents

1 reference

12 December 2020

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

1 reference

12 December 2020

Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00441953

1 reference

Dimensions Publication ID

29 September 2017

0 references

1 reference